Pacira BioSciences (PCRX) EV to CFO (2011 - 2026)

Pacira BioSciences has reported EV to CFO for 16 years, with the latest figure at 13.21 in Q2 2026.

• On a quarterly basis, EV to CFO fell 74.69% year-over-year to 13.21 in Q2 2026; TTM through Jun 2026 was 4.05, a 13.22% decrease from a year earlier, with the FY2025 full-year figure at 5.43, up 166.15% from the prior year.
• EV to CFO was 13.21 for Q2 2026 at Pacira BioSciences, down from 26.72 in the prior quarter.
• The five-year high for EV to CFO was 97.06 in Q1 2022, with the low at 4.46 in Q3 2024.
• Average EV to CFO over 5 years is 35.52, with a median of 26.74 recorded in 2023.
• The sharpest annual moves came in 2024 and 2025: EV to CFO plunged 83.32% in 2024, then jumped 216.99% in 2025.
• Over 5 years, EV to CFO stood at 35.32 in 2022, then decreased by 23.26% to 27.1 in 2023, then slumped by 56.95% to 11.67 in 2024, then jumped by 61.98% to 18.9 in 2025, then sank by 30.08% to 13.21 in 2026.
• The last three EV to CFO figures came in at 13.21 (Q2 2026), 26.72 (Q1 2026), and 18.9 (Q4 2025), per Business Quant data.